Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 (Study)

https://clinicaltrials.gov/ct2/show/NCT04604678

Pilot study into low dose naltrexone (LDN) and NAD+ for treatment of patients with post-COVID-19 syndrome (Study)

https://clinicaltrials.gov/ct2/show/NCT04604704

This study will assess the use of low dose naltrexone (LDN) and NAD+ for the treatment of patients with post-COVID-19 syndrome (long-COVID-19).

 

Yoon Hang "John" Kim, MD - Getting the most of LDN treatment and Beyond LDN (2019 Conference) (LDN, low dose naltrexone)

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis


BMC Medicine
15 January  2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0

 

Dana Keaton, ND - Patient selection and inflammation (2019 Conference) (LDN, low dose naltrexone)

Dr. Dana Keaton, Patient selection and inflammation

Naltrexone a potential therapeutic candidate for COVID-19 (Abstract)

J Biomol Struct Dyn
15 Sept 2020
https://pubmed.ncbi.nlm.nih.gov/32930058/

Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic (Abstract)

Res Social Adm Pharm
12 Nov 2020
https://pubmed.ncbi.nlm.nih.gov/33221267/

Effects of Naloxone and Naltrexone on Locomotor Activity in C57BL/6 and DBA/2 Mice

APA Psychnet
April 1982
https://psycnet.apa.org/record/1982-29877-001

Subscribe to Medications